Profile: MediBIC Group (2369.T)

MediBIC Group is a Japan-based company comprised of five business segments. The Biomarker Drug Discovery segment provides support solution services for new drug development, including the provision of analytical, clinical trial coordinate, data analytical and pharmacogenomics (PGx) test support services, as well as the sale of development support products and system architecture business, The Tailor-made Healthcare Support segment provides private deoxypentose nucleic acid (DNA) bank services and sells hyaluronan, vanadium water and other healthy products. The Drug Discovery segment adds value to candidate compounds of genomic, advanced and general new drugs to acquire part of intellectual properties. The Investment and Incubation segment is engaged in the management and operation of funds, and the trading of securities. The Others segment is engaged in the holding of seminars and forums for researchers. MediBIC has seven consolidated subsidiaries.